Production Assistance for Cellular Therapies (PACT)- Cell Processing Facilities Cell manufacturing and process development services for RSA PCT0035-01: Preclinical Development of PB-derived iTregs

NIH RePORTER · NIH · N01 · $561,544 · view on reporter.nih.gov ↗

Abstract

The objective of this project is to develop an optimized approach to isolation and expansion of peripheral blood-derived iTregs.

Key facts

NIH application ID
10115183
Project number
268201600014I-0-759202000001-1
Recipient
UNIVERSITY OF MINNESOTA
Principal Investigator
DAVID MCKENNA
Activity code
N01
Funding institute
NIH
Fiscal year
2020
Award amount
$561,544
Award type
—
Project period
2019-11-01 → 2020-10-31